PeerView Oncology & Hematology CME/CNE/CPE Video Podcast

PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.

http://ww2.peerview.com

Eine durchschnittliche Folge dieses Podcasts dauert 1h0m. Bisher sind 724 Folge(n) erschienen. Dieser Podcast erscheint alle 2 Tage.

Gesamtlänge aller Episoden: 30 days 6 hours 46 minutes

subscribe
share






Nasser Altorki, MD - How to Integrate Perioperative Immunotherapy Into Multimodal Treatment Plans to Improve Outcomes in Resectable NSCLC


Go online to PeerView.com/GWF860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 June 15, 2022  49m
 
 
share








 June 15, 2022  1h21m
 
 

Amy Goodrich, CRNP - Hope Is Here in CLL: Oncology Nurse Strategies for Delivering Effective, Compassionate, and Modern Care to Patients


Go online to PeerView.com/QWZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 June 15, 2022  1h15m
 
 

Prof. Solange Peters, MD, PhD - Parsing the Practicalities of Pathologic Response Assessment After Neoadjuvant Immunotherapy to Facilitate Progress in Early-Stage Cancers


Go online to PeerView.com/HCZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 May 31, 2022  1h31m
 
 

Linda Ahn, MSN, ANP-BC, AOCNP - Tackling the Practicalities of Antibody–Drug Conjugate Therapy for Solid Tumors: Improving Clinical Care With HER2-, HER3-, and TROP2-Targeted Therapies


Go online to PeerView.com/PFM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 May 31, 2022  1h5m
 
 

Kurt A. Schalper, MD, PhD - Progress and Practicalities in Immunotherapy Biomarker Testing and Pathologic Response Assessment in Solid Tumors: What’s New and What You Need to Know and Do


Go online to PeerView.com/KCV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 May 26, 2022  1h26m
 
 

Mark A. Socinski, MD - Expanding Options, Lingering Questions: How to Select the Right Immunotherapy for First-Line Treatment of Advanced NSCLC


Go online to PeerView.com/JBW860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 May 24, 2022  1h10m
 
 

Erika Hamilton, MD - How to Harness Adjuvant CDK4 and 6 Inhibition to Prevent Recurrences in High-Risk HR+/HER2- Early Breast Cancer: New Goals and Better Tools to Close the Gaps


Go online to PeerView.com/WFC860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 May 24, 2022  58m
 
 

Nina Shah, MD - Mapping the Therapeutic Odyssey in Multiple Myeloma: Interprofessional Guidance on Evidence-Based Treatment Selection and Sequencing


Go online to PeerView.com/MZJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 May 20, 2022  1h5m
 
 

Jacob Sands, MD - Weighing the Evidence, Parsing the Practicalities: Integrating New Treatment Options Into the SCLC Treatment Arsenal to Improve Patient Outcomes in Oncology Practice


Go online to PeerView.com/PYK860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 May 20, 2022  1h9m